Is Knowledge Power? Developing An Infrastructure That Enhances Patient Safety Pharmacy CQI In Florida David B. Brushwood, R.Ph., J.D. Professor of Pharmacy.

Slides:



Advertisements
Similar presentations
Safety in the Pharmacy Health Science Technology.
Advertisements

Common/shared responsibilities between jobs.
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Hospital Pharmacy Workflow
Medication Management
Learning Objectives Understand the Mission of Pharmacy Benefits Management Understand the Background on Pharmacy Re-Engineering Project (PRE) including.
Presentation for the Management Study of the Code Enforcement Process City of Little Rock, Arkansas August 3, 2006.
CQC registration for providers of Primary Dental Services Medicines Management Caroline Crouch NHS Dorset.
 Definition of medicines management  Incidents reported  How medications errors are reported  Actions taken to prevent reoccurrence  Role of the.
Medication Regimen Review Guidance Training CFR § (c)(1)(2) F428.
David B. Brushwood, R.Ph., J.D. Professor of Pharmaceutical Outcomes and Policy The University of Florida College of Pharmacy.
Drug Utilization Review (DUR)
Topic 1 What is patient safety?. Understand the discipline of patient safety and its role in minimizing the incidence and impact of adverse events, and.
Medication Therapy Management Linda Mach, PharmD Bartell Drugs Community Practice Resident February 26, 2010.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Omnibus Budget Reconciliation Act (OBRA-90) Goal To save money.
THE HOSPITAL AND THE DEPARTMENT OF PHARMACEUTICAL SERVICES.
a judgment of what constitutes good or bad Audit a systematic and critical examination to examine or verify.
Quality Improvement Prepeared By Dr: Manal Moussa.
IHS Pharmacy Policies and Procedures
Internal Auditing and Outsourcing
Great Plains Veterinary Educational Center A Little On Drug Use Antibiotic Use GuidelinesAMDUCA (Animal Medicinal Drug Use Clarification Act)ELDU (Extra.
Criteria and Standard.
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
Continuous Quality Improvement Drug Utilization Evaluation.
Responsibilities and Principles of Drug Administration
Medication Error Nasha’at Jawabreh And yousef. What is the definition of medication error ?
The Value of Medication Therapy Management Services.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
April 15 th is not just the deadline for your taxes!!! Is your documentation complete for Pharmacist to Registered Technician Ratios? Policies.
1 Visioning the 21 st Century Health System Kenneth I. Shine, MD National Health Information Infrastructure 2003: Developing a National Action Agenda for.
Florida Agency for Health Care Administration Florida Center for Health Information and Policy Analysis Florida Public Health Association - Medical Director’s.
Rational Prescribing & Prescription Writing Collected and Prepared By S.Bohlooli, Pharm.D, PhD.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Pharmacy 483: Steve Riddle, BS Pharm, BCPS QI and Medication Utilization Lead HMC Pharmacy February 22, 2005 Quality Improvement in Pharmacy.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
ASPECTS AFFECTING THE HOSPITAL OPERATION Financial Financial Operational Operational Administrative Administrative Clinical Clinical Safety Safety.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Determinants of Rational Use of Medicines Dr A K Sharma Prof & Head Dept of Pharmacology AFMC, Pune.
Medication Error Reduction Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Dispensary and Administration Site Information Presentation.
Rational Prescribing & Prescription Writing Once a patient with a clinical problem has been evaluated and a diagnosis has been reached, the practitioner.
Guidance Training (F520) §483.75(o) Quality Assessment and Assurance.
Introduction.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Establishing and Maintaining Effective Safety Committees.
McLaughlin and Kaluzny, Continuous Quality Improvement in Health Care, 3 rd Ed.
1 Processing Claims and Appealing Decisions Chapter 7 © 2010 The McGraw-Hill Companies, Inc. All rights reserved.
What is HIPAA? Health Insurance Portability and Accountability Act of HIPAA is a major law primarily concentrating on the prolongation of health.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Assuring Compliance with the JCAHO 2004 Standards: Medication Management Patricia C. Kienle, RPh, MPA, FASHP Medication Safety Manager Cardinal Health.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
HOSPITAL ACCREDITATION & RETAINING QUALITY
Collaborative Practice Agreements
April 15th is not just the deadline for your taxes
History of the development of the pharmaceutical care
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Critical Care Services Pharmacist Royal Manchester Children’s Hospital
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Clinical practice guidelines and Clinical audit
Controlling Measuring Quality of Patient Care
Drug Information Resources
Medication Safety Dr. Kanar Hidayat
Pharmacy practice experience I
Pharmacy practice experience I
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
National Credentialing Forum 2019 San Diego, CA February
Medication Safety Dr. Kanar Hidayat
Presentation transcript:

Is Knowledge Power? Developing An Infrastructure That Enhances Patient Safety Pharmacy CQI In Florida David B. Brushwood, R.Ph., J.D. Professor of Pharmacy Health Care Administration The University of Florida College of Pharmacy

Who says the system is broken? The media –Television programs –Magazines –Newspapers State regulators The courts The IOM Report But… –No pharmacist wants to make a mistake –No pharmacy manager wants pharmacists to make a mistake Maybe the system just needs to be organized better.

Harco Drugs v. Holloway 669 So.2d 878 (Ala. 1995). “We note that the jury was also informed of 233 incident reports that had been prepared by Harco employees during the three years preceding the incident. This evidence, in addition to evidence of complaints filed with the State Board of Pharmacy and the evidence of lawsuits filed alleging misfilled prescriptions, was relevant to show Harco’s knowledge of problems, and Harco’s having failed to initiate sufficient institutional controls over the manner in which prescriptions were filled.”

Alternative Responses Do Nothing. Punishment. –Advantages Practical Appeal. Political Appeal. Emotional Appeal. –Disadvantages Ineffective –Too little –Too much Unreliable Unfair Centralized Data Reporting and Feedback Centralized QA Program Error Prevention Clinic Mandatory or Recommended CQI Regulating for Outcomes (Responsive Regulation) Brennan and Berwick, New Rules (1996).

Ten (Possible) Approaches Continuous Quality Improvement Program Professional Performance Evaluation Consumer Surveys Criteria and Standards Localized Minimum Data Set Periodic Self Audit Centralized Performance Database Practice Accountability Audit Initial Licensure by Portfolio Relicensure by Portfolio

Continuous Quality Improvement Identify and record failures of quality. Take a systems view. Involve all personnel. Learn from past and plan for improved future. Records available for inspection.

CQI Program

Consumer Surveys Conducted at least once per year. Pertinent Questions –Is the pharmacist accessible? –Can you read your prescription label? –Is your drug therapy helping you get better? Evidence of completion available for inspection.

Consumer Surveys

Criteria and Standards Criterion: Predetermined elements with which comparison can be made. –Example: No refills more frequently than day’s supply indicates. Standard: Acceptable variation from criterion. –Example: Within 20% (6 days for 30 day period) ok.

Criteria and Standards

Periodic Self Audit Have criteria and standards been met? –Drug-drug interaction overrides. –Duplicative drug therapy. –Absence of documented patient education. Benchmark over time.

Periodic Self Audit

Centralized Performance Database Aggregate data from a large number of practice sites. –Uploaded to board. –Purchased from payer. Picture of quality throughout state. Compare practice sites.

Centralized Performance Database

Practice Accountability Audit Evaluates Performance Database Triggered by violation of criteria/standards Request explanation of violation. Done by board or by profession.

Practice Accountability Audit

CQI as a Risk Management System RPh. & P.T. dispense according to established Procedures Quality related event occurs Quality Supervisor Reviews Telephone Reports and in-store documentation Quality Supervisor Reviews Quality Inservice Developed Management Kept Informed of Progress Management Reviews Policies and Adjusts PRN Quality Consult held

CQI and the Florida BOP –(2) "Quality ‑ Related Event" means the inappropriate dispensing of a prescribed medication including: –(a) a variation from the prescriber's prescription order, including, but not limited to: –1. dispensing an incorrect drug; –2. dispensing an incorrect drug strength; –3. dispensing an incorrect dosage form; –4. dispensing the drug to the wrong patient; or –5. providing inadequate or incorrect packaging, labeling, or directions. –(b) a failure to identify and manage: –1. over ‑ utilization or under ‑ utilization; –2. therapeutic duplication; –3. drug ‑ disease contraindications; –4. drug ‑ drug interactions; –5. incorrect drug dosage or duration of drug treatment; –6. drug ‑ allergy interactions; or –7. clinical abuse/misuse. 64B16 ‑ Standards of Practice ‑‑ Continuous Quality Improvement Program. (1) "Continuous Quality Improvement Program" means a system of standards and procedures to identify and evaluate quality ‑ related events and improve patient care.

CQI Components P&P Manual CQI Committee Record QREs Review Record at least once every 3 months –staffing levels –workflow –technological support Summarization Document (no identifiers) Protection from Discovery ( FS)

RESULTS Inspector looks for evidence of CQI program and compliance. Inspector is educator and enabler, to prevent errors not react to them. Punishment for failure to conduct CQI, not for failure to be perfect. Commercial product available.